Evogene Ltd.EVGNNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank5
Year-over-Year Change
Year-over-year gross profit growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-10.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -127.51% |
| Q2 2025 | 82.47% |
| Q1 2025 | -4.56% |
| Q4 2024 | -46.22% |
| Q3 2024 | 901.64% |
| Q2 2024 | -101.90% |
| Q1 2024 | 764.39% |
| Q4 2023 | -118.61% |
| Q3 2023 | 671.59% |
| Q2 2023 | -40.99% |
| Q1 2023 | 6.67% |
| Q4 2022 | -15.38% |
| Q3 2022 | 46.89% |
| Q2 2022 | 7.25% |
| Q1 2022 | -19.49% |
| Q4 2021 | -2.01% |
| Q3 2021 | 12.17% |
| Q2 2021 | -13.86% |
| Q1 2021 | 20.06% |
| Q4 2020 | -30.61% |
| Q3 2020 | 12.48% |
| Q2 2020 | 11.67% |
| Q1 2020 | 2.68% |
| Q4 2019 | 17.56% |
| Q3 2019 | -31.23% |
| Q2 2019 | -62.33% |
| Q1 2019 | -4612.50% |
| Q4 2018 | 102.32% |
| Q3 2018 | -7.45% |
| Q2 2018 | 7.04% |
| Q1 2018 | -444.56% |
| Q4 2017 | -50.50% |
| Q3 2017 | 26.25% |
| Q2 2017 | 116.22% |
| Q1 2017 | 51.02% |
| Q4 2016 | -58.48% |
| Q3 2016 | -49.36% |
| Q2 2016 | -53.49% |
| Q1 2016 | 9.63% |
| Q4 2015 | -44.40% |